Clinical and genetic characteristics of hypophosphatasia in Chinese children

• Published in: Orphanet journal of rare diseases Vol. 16; no. 1; p. 159
• Main Authors: Liu, Meijuan, Liu, Min, Liang, Xuejun, Wu, Di, Li, Wenjing, Su, Chang, Cao, Bingyan, Chen, Jiajia, Gong, Chunxiu
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 07.04.2021; BioMed Central; BMC
• Subjects: Abdomen; Alkaline phosphatase; Alkaline Phosphatase - genetics; ALPL; Biochemistry; Birth; Bone density; Bones; Calcium; Calcium (blood); Child; Child, Preschool; Children; China; China - epidemiology; Diagnosis; Exons; Female; Frameshift mutation; Genetic analysis; Genetic aspects; Genetic counseling; Humans; Hypophosphatasia; Hypophosphatasia - epidemiology; Hypophosphatasia - genetics; Kidneys; Male; Medical research; Mineralization; Missense mutation; Mutation; Mutation - genetics; Mutations; Parathyroid; Parathyroid hormone; Patients; Pediatric research; Phenotype; Phenotypes; Phosphatase; Rare diseases; Ultrasonic imaging; China; Beijing China; Mutations; ALPL; Children; Hypophosphatasia; China
• ISSN: 1750-1172; 1750-1172
• DOI: 10.1186/s13023-021-01798-1

Hypophosphatasia (HPP) is a rare inherited disorder, which is caused by loss-of-function mutations in the ALPL gene. HPP is a heterogeneous disease that has a wide spectrum of phenotypes. Few studies were carried out in the Chinese population with HPP, especially in children. The clinical and genetic characteristics of 10 Chinese children with HPP who were referred to the Beijing Children's Hospital were described. Previously reported HPP cases of children in China were also reviewed. A total of 33 cases were identified, which included 2 perinatal lethal HPP, 10 infantile HPP, 10 childhood HPP, and 11 odonto HPP. The male-to-female ratio was 24:9. The average age at onset was 0.69 years (ranged from 2 h after birth to 14 years), while the average age at clinical diagnosis was 3.87 years (ranged from 2 h after birth to 19 years). Serum alkaline phosphatase (ALP) levels were significantly decreased in patients with perinatal lethal/infantile HPP when compared with those with the mild forms of HPP childhood/odonto HPP (P < 0.01). Although serum phosphate levels were not different (P > 0.05), serum calcium levels were elevated, and serum intact parathyroid hormone levels were decreased in patients with perinatal lethal/infantile HPP in comparison with those with the childhood/odonto HPP (P all < 0.01). Genetic analyses identified 40 mutations in 31 HPP cases, including 28 missense mutations, 9 frameshift mutations, 2 splice junction alterations, and 1 regulatory mutation. Of which, 5 novel mutations were identified in our present study: 2 frameshift mutations (p.Arg138GlyfsTer27, p.Leu511Profs*272); 2 missense mutations (p.Ala176Val, p.Phe268Leu), and 1 splice junction alteration (c.297+5G>A). Compound heterozygous mutations accounted for 80.6% of all variants. No mutational "hot-spot" was found. Most mutations of ALPL were located in exons 5, 7, 10, and 3. Notably, subjects that carrying single heterozygous mutations showed milder phenotypes of HPP, while subjects with nonsense mutations were associated with a severer phenotype. HPP is a rare disease with often delayed diagnosis, and the incidence of HPP in China may be seriously underestimated. The present study expands the phenotypic and genotypic spectrum and the understanding of HPP in Chinese children. These findings will be useful for clinical assessment and shorten the diagnosis time for pediatric HPP in China.